Inotuzumab MMAE Antibody
This product is the antibody-drug conjugate inotuzumab ozogamicin, a recombinant human IgG1 anti-CD22 antibody produced in CHO cells. It is utilized in research to study targeted cytotoxicity against CD22-expressing B-cell malignancies in both in vitro and in vivo models.
Product Specifications
Target
Immunology/Inflammation related
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Molecular Weight
145 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041003-100 1x 100 µL
Mucin 5AC (MUC5AC) (58M1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471073-100 1x 100 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040003-500 1x 500 µL
CD45RO (UCHL-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740745-500 1x 500 µL
CD45 / LCA (2B11 + PD7/26), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682197-100 1x 100 µL
HCG-beta (Pregnancy & Choriocarcinoma Marker) (rHCGb/54), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details